Antimicrobial prophylaxis in hematopoietic stem cell transplantation recipients: 10 years after

被引：8
作者：
Trifilio, S.
Mehta, J.
机构：
[1] Northwestern Univ, Robert Lurie Canc Ctr, Dept Hematol & Oncol, Chicago, IL 60611 USA
[2] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
来源：
TRANSPLANT INFECTIOUS DISEASE | 2014年 / 16卷 / 04期
关键词：
antimicrobial prophylaxis; stem cell transplantation; infection; survey; guidelines; INVASIVE FUNGAL-INFECTIONS; FLUCONAZOLE; VORICONAZOLE; DISEASE; PREVENTION; ACYCLOVIR; MORTALITY; TRIAL;
D O I：
10.1111/tid.12237
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Background Antimicrobial prophylaxis is recommended for all patients undergoing hematopoietic stem cell transplantation. Evidence-based guidelines recently have been updated to incorporate the results from recent clinical studies. Methods An antimicrobial prophylaxis survey was conducted during the 2013 ASBMT Tandem Meetings to discern the degree of concordance between transplant centers and society guidelines. Results The results show significant differences in prescribing practices among transplant institutions and variance with evidence-based guidelines. Conclusion The clinical significance of this discordance is unknown.
引用
收藏
页码：548 / 555
页数：8
相关论文
共 19 条
[1]  
[Anonymous], HEMATOL AM SOC HEMAT
[2]   Valacyclovir prophylaxis for the prevention of Herpes simplex virus reactivation in recipients of progenitor cells transplantation [J].
Dignani, MC ;
Mykietiuk, A ;
Michelet, M ;
Intile, D ;
Mammana, L ;
Desmery, P ;
Milone, G ;
Pavlovsky, S .
BONE MARROW TRANSPLANTATION, 2002, 29 (03) :263-267
[3]   One-year acyclovir prophylaxis for preventing varicella-zoster virus disease after hematopoietic cell transplantation: no evidence of rebound varicella-zoster virus disease after drug discontinuation [J].
Erard, Veronique ;
Guthrie, Katherine A. ;
Varley, Cara ;
Heugel, Judson ;
Wald, Anna ;
Flowers, Mary E. D. ;
Corey, Lawrence ;
Boeckh, Michael .
BLOOD, 2007, 110 (08) :3071-3077
[4]   Use of long-term suppressive acyclovir after hematopoietic stem-cell transplantation: Impact on herpes simplex virus (HSV) disease and drug-resistant HSV disease [J].
Erard, Veronique ;
Wald, Anna ;
Corey, Lawrence ;
Leisenring, Wendy M. ;
Boeckh, Michael .
JOURNAL OF INFECTIOUS DISEASES, 2007, 196 (02) :266-270
[5]   Meta-analysis: Antibiotic prophylaxis reduces mortality in neutropenic patients [J].
Gafter-Gvili, A ;
Fraser, A ;
Paul, M ;
Leibovici, L .
ANNALS OF INTERNAL MEDICINE, 2005, 142 (12) :979-995
[6]   Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy [J].
Gafter-Gvili, Anat ;
Fraser, Abigail ;
Paul, Mical ;
Vidal, Liat ;
Lawrie, Theresa A. ;
van de Wetering, Marianne D. ;
Kremer, Leontien C. M. ;
Leibovici, Leonard .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (01)
[7]   Voriconazole provides effective prophylaxis for invasive fungal infection in patients receiving glucocorticoid therapy for GVHD [J].
Gergis, U. ;
Markey, K. ;
Greene, J. ;
Kharfan-Dabaja, M. ;
Field, T. ;
Wetzstein, G. ;
Schell, M. J. ;
Huang, Y. ;
Anasetti, C. ;
Perkins, J. .
BONE MARROW TRANSPLANTATION, 2010, 45 (04) :662-667
[8]   Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001-2006: Overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database [J].
Kontoyiannis, Dimitrios P. ;
Marr, Kieren A. ;
Park, Benjamin J. ;
Alexander, Barbara D. ;
Anaissie, Elias J. ;
Walsh, Thomas J. ;
Ito, James ;
Andes, David R. ;
Baddley, John W. ;
Brown, Janice M. ;
Brumble, Lisa M. ;
Freifeld, Alison G. ;
Hadley, Susan ;
Herwaldt, Loreen A. ;
Kauffman, Carol A. ;
Knapp, Katherine ;
Lyon, G. Marshall ;
Morrison, Vicki A. ;
Papanicolaou, Genovefa ;
Patterson, Thomas F. ;
Perl, Trish M. ;
Schuster, Mindy G. ;
Walker, Randall ;
Wannemuehler, Kathleen A. ;
Wingard, John R. ;
Chiller, Tom M. ;
Pappas, Peter G. .
CLINICAL INFECTIOUS DISEASES, 2010, 50 (08) :1091-1100
[9]   Voriconazole is safe and effective as prophylaxis for early and late fungal infections following allogeneic hematopoietic stem cell transplantation [J].
Martin, T. ;
Sharma, M. ;
Damon, L. ;
Kaplan, L. ;
Guglielmo, B. J. ;
Working, M. ;
O'Malley, R. ;
Hwang, J. ;
Linker, C. .
TRANSPLANT INFECTIOUS DISEASE, 2010, 12 (01) :45-50
[10]   Epidemiology, outcomes, and mortality predictors of invasive mold infections among transplant recipients: a 10-year, single-center experience [J].
Neofytos, D. ;
Treadway, S. ;
Ostrander, D. ;
Alonso, C. D. ;
Dierberg, K. L. ;
Nussenblatt, V. ;
Durand, C. M. ;
Thompson, C. B. ;
Marr, K. A. .
TRANSPLANT INFECTIOUS DISEASE, 2013, 15 (03) :233-242
12